LAVAL, Quebec, July 15, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to host a conference call and live webcast on August 9, 2016 to discuss second quarter 2016 financial results.
Conference Call Details:
Tuesday, August 9, 2016
8:00 a.m. ET
Participant Event Dial-in
(877) 876-8393 (North America)
(973) 200-3961 (International)
(855) 859-2056 (North America)
(404) 537-3406 (International)
48835456 (Replay available until August 17, 2016)
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Laurie W. Little
877-281-6642 (toll free)
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-announces-second-quarter-results-conference-call-date-and-details-300299291.html
SOURCE Valeant Pharmaceuticals International, Inc.